# Autologous Adipose Derived Stem Cell Therapy for Intervertebral Disc Degeneration

> **NCT02338271** · PHASE1 · UNKNOWN · sponsor: **Inbo Han** · enrollment: 10 (estimated)

## Conditions studied

- Low Back Pain

## Interventions

- **OTHER:** autologous adipose derived mesenchymal stem cell

## Key facts

- **NCT ID:** NCT02338271
- **Lead sponsor:** Inbo Han
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2015-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02338271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02338271, "Autologous Adipose Derived Stem Cell Therapy for Intervertebral Disc Degeneration". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02338271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*